Yi Hsu Huang
Director/Board Member chez ADVAGENE BIOPHARMA CO., LTD.
Profil
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Postes actifs de Yi Hsu Huang
| Sociétés | Poste | Début |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 06/04/2016 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Anciens postes connus de Yi Hsu Huang
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 01/05/2021 |
| MYCENAX BIOTECH INC. | Founder | 15/08/2019 |
Formation de Yi Hsu Huang
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| National Health Research Institutes |
